Evidence Roadmap

Clear evidence labels for a therapist-led AI platform.

We separate current guideline-grounded clinical decision support from workflow-impact evidence we are collecting and outcomes we do not claim.

Current evidence base for Citt Evidence

Citt Evidence is clinical decision support for therapists. It is grounded in curated guideline summaries and therapist resources, not positioned as a standalone clinical authority.

NICE

nice-ng193-chronic-pain

APA

apa-cbt-evidence-base

NICE

nice-cg22-anxiety

WHO

who-mhgap-2023

Cochrane

cochrane-psych-chronic-pain

NICE

nice-ng87-adhd-adults

APA

apa-ptsd-2017

APA

apa-mdd-2010

NICE

nice-cg185-bipolar

APA

apa-bipolar-2002

NICE

nice-ng69-eating-disorders

NICE

nice-cg31-ocd

NICE

nice-cg78-bpd

NICE

nice-ng215-insomnia

NICE

nice-substance-use-overview

APA

apa-social-anxiety-2009

NICE

nice-ng116-ptsd

Cochrane

cochrane-depression-psychotherapy

Workflow-impact evidence we are collecting

These are roadmap measurement areas. They are not marketed as proven product impact until measured and reviewed.

Patient engagement with check-ins and between-session support
No-show and attendance patterns
Clinical note turnaround time
Therapist review workload and response patterns
Patient consent and device delivery preferences

Evidence we are not claiming yet

These claims require evidence that Citt.ai is not currently presenting as measured product proof.

Clinical efficacy for treating a condition
Equivalence to therapy delivered by a licensed clinician
A guarantee that risk screening catches every crisis
A measured capacity multiplier for how many patients a therapist can support
Autonomous diagnosis, treatment, or medication advice